End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.4 CNY | +0.95% | -5.47% | +37.34% |
Apr. 23 | China stocks down, dragged by cyclical shares; HK shares up | RE |
Apr. 22 | Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 17.75B 2.45B | Sales 2025 * | 18.76B 2.59B | Capitalization | 10.63B 1.47B |
---|---|---|---|---|---|
Net income 2024 * | 1.1B 152M | Net income 2025 * | 1.22B 169M | EV / Sales 2024 * | 0.6 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.57 x |
P/E ratio 2024 * |
9.7
x | P/E ratio 2025 * |
8.77
x | Employees | 9,012 |
Yield 2024 * |
4.38% | Yield 2025 * |
4.69% | Free-Float | 36.69% |
1 day | +0.95% | ||
1 week | -5.47% | ||
1 month | +13.07% | ||
3 months | +52.02% | ||
6 months | +25.00% | ||
Current year | +37.34% |
Managers | Title | Age | Since |
---|---|---|---|
Jun Ying
CEO | Chief Executive Officer | 51 | 19-09-23 |
Jun Lai Chen
DFI | Director of Finance/CFO | 49 | 21-10-14 |
Xiao Long Yan
BRD | Director/Board Member | 51 | 23-09-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lei Zhang
BRD | Director/Board Member | 55 | 13-09-17 |
Wu Chen
BRD | Director/Board Member | 56 | 11-01-31 |
Rong Dan Xu
DFI | Director of Finance/CFO | 48 | 20-02-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 6.4 | +0.95% | 45,716,000 |
24-06-03 | 6.34 | -0.94% | 52,157,600 |
24-05-31 | 6.4 | -1.39% | 52,901,000 |
24-05-30 | 6.49 | -3.57% | 83,122,650 |
24-05-29 | 6.73 | -0.59% | 68,202,370 |
End-of-day quote Shanghai S.E., June 03, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+37.34% | 1.45B | |
-5.06% | 27.3B | |
+18.95% | 24.54B | |
+6.76% | 11.21B | |
+11.41% | 5.1B | |
+17.70% | 4.33B | |
-9.89% | 3.68B | |
+2.58% | 3.46B | |
+25.94% | 2.78B | |
-2.31% | 2.78B |
- Stock Market
- Equities
- 600866 Stock